Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-25-004461

Head of Pharm Ops and Tech gave up 670 shares (to pay taxes)

  • Head of Pharm Ops and Tech acquired 2,272 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Murphy Nicole · Head of Pharm Ops and Tech

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-10 Exercise or conversion : show line 1 in the form +2,272 14,725.37 D
2025-02-10 Shares withheld for taxes : show line 2 in the form −670 $142.54 $95,502 14,055.37 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-10 Exercise or conversion : show line 3 in the form Restricted Stock Unit −2,272 0 D
Loading xslF345X05/form4.xml…